Abstract
The occurrence and the possible role in promoting HIV infection by human herpesvirus type 6 (HHV-6) have not yet been revealed in Hungary. In different groups of patients, serum titre of IgM and IgG antibodies, as well as avidity of IgG were quantitated by indirect immunofluorescence and an enzyme-linked immunosorbent assay, using isolate U1102 of HHV-6 variant A as antigen. In 60% of HIV-seronegative adult controls, high avidity IgG antibodies were found in low titre suggesting childhood infection. In HIV-seronegative persons with high risk behaviour for HIV-infection, both IgM and low avidity IgG were frequently found in higher titre, representing either primary or frequent reinfections, or reactivation of latent HHV-6. In asymptomatic HIV-seropositive patients, high titre of high avidity IgG antibodies was predominant, proving virus infection in the near past. These results indicate the contribution of HHV-6 to immunosuppression prior to AIDS, predisposing the organism to HIV infection.
Similar content being viewed by others
References
Ablashi DV, Salahuddin SZ, Josephs SF, et al: HBLV (or HHV-6) in human cell lines. Nature 329:207, 1987.
Ablashi DV, Lusso P, Hung CL, et al: Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus-6). Int.J.Cancer 42:787–791, 1988.
Ablashi DV, Balachandran N, Josephs SF, et al: Genomic polymorphism, growth properties, and immunogenic variations in human herpesvirus-6 isolates. Virology 184:545–552, 1991.
Bovenzi P, Mirandola P, Secchiero P, et al: Human herpesvirus 6 (variant A) in Kaposis sarcoma. Lancet 341:1288–1289, 1993.
Briggs M, Fox J and Tedder RS: Age prevalence of antibody to human herpesvirus-6. Lancet 1:1058–1059, 1988.
Chandran B, Tirawatnapong S, Pfeiffer B, Ablashi DV: Antigenic relationships among human herpesvirus-6 isolates. J Med.Virol 37:247–254, 1992.
Chen M, Popescu N, Woodworth C, et al: Human herpesvirus 6 infects cervical epithelial cells and transactivates papillomavirus gene expression. J Virol. 68:1173–1178, 1994.
Dahl H, Linde A, Sundquist V, Wahren B: An enzyme-linked immunosorbent assay for IgG antibodies to human herpesvirus6. J Virol.Methods 29:313–324, 1990.
D Luca D, Dolcetti R, Mirandola P, et al: Human herpesvirus 6: A survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Inf Dis 70:211–215, 1994.
Di Luca D, Zorzenon M, Mirandola P, et al: E: Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J Clin Microbiol. 33:1660–1661, 1995.
Ensoli B, Lusso P, Schachter F, et al: Human herpesvirus-6 increases HIV expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J. 8:3019–3027, 1989.
Flamand L, Stefanescu I, Ablashi DV, Menenzes J: Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol. 67:6768–6777, 1993.
Fox J, Briggs M and Tedder RS: Antibody to human herpesvirus-6 in HIV-positive and negative homosexual men. Lancet ii:396, 1988.
Gosselin J, Flamand L, D’Addario M, et al: Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. J Immunol. 149:181–187, 1992.
Iuliano R, Trovato R, Lico S, et al: Human herpesvirus 6 reactivation in a longitudinal study of two HIV-1 infected patients. J Med Virol. 51:259–264, 1997.
Knox KK, Carrigan DR: Disseminated active HHV-6 infections in patients with AIDS. Lancet 343:577–578, 1993.
Levy JA, Ferro F, Greenspan D, Lennette ET: Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 335:1047–1050, 1990.
Levy JA: Three new human herpesviruses (HHV-6, 7, and 8). Lancet 349:558–562, 1997.
Levy JA, Ferro F, Lennette ET, et al: Characterization of new strain of HHV-6 (HHV-6SF) recovered from saliva of an HIV infected individual. Virology 178:113–121, 1990.
Linde A, Fridell E, Dahl H, et al: Effect of primary EpsteinBarr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers. J Clin Microb 28:211–215, 1990.
Lindquester GJ, Inoue N, Allen RD, et al: Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 varian B strain Z29 genome. Arch Virol 141:367–369, 1996.
Lusso P, De Maria A, Malnati M, et al: Induction of CD4 and susceptibility to HIV infection in human CD8+ lymphocytes by human herpesvirus 6. Nature 349:533–535, 1991.
Lusso P, Markham PD, DeRocco SE, Gallo RC: In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med 167:1659–1670, 1988.
Lusso P, Gallo RC: Human herpesvirus 6 in AIDS. Lancet 343:555–556, 1994.
Nagy K, Barabás É, Várkonyi V, Horváth A: Determination of HIV-1 subtypes in Hungary by synthetic peptides representing the V3 loop of env. Pathol Oncol Res 2:268–271, 1996.
Ongrádi J, Ceccherini-Nelli L, Soldaini E, et al: Endotoxin suppresses indirect activation of HIV-1 by human herpesvirus 6. In: Cellular and molecular aspects of endotoxin reactions. (Eds: Nowotny A, Spitzer JJ and Ziegler E), Elsevier Science BV, Amsterdam, 1990, pp. 387–394.
Ongrádi J, Iuliano R, Rossi M, Ceccherini-Nelli L: Transcellular transactivation of HIV-1 by HHV-6. Acta Microbiol. Immunol Hung 41, S52, 1994.
Pass RF, Griffiths PD and August AM: Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Inf Dis 147:40–46, 1983.
Salahuddin SZ, Ablashi DV, Markham PD, et al: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596–601, 1986.
Schirmer EC, Wyatt LS, Yamanishi K, et al: Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci USA 88:5922–5926, 1991.
Takahashi K, Sonoda S, Higashi K, et al: Predominant CD4 T lymphocyte tropism of human herpesvirus-6 related virus. J Virol 63:3161–3163, 1989.
Yamanishi K, Okuno T, Shiraki K, et al: Identification of human herpesvirus-6 as a casual agent for exanthema subitum. Lancet 1:1065–1067, 1988.
Ward KN, Gray JJ, Fotheringham MW, Sheldon MJ: IgG antibodies to human herpesvirus-6 in young children: Changes in avidity of antibody correlate with time after infection. J Med Virol 39:131–138, 1993.
Ward KN, Gray JJ, Joslin ME, Sheldon MJ: Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes crossreactivity with other herpesviruses. J Med Virol 39:44–49, 1993.
Wyatt LS, Balachandran N, Frenkel N: Variations in the replication and antigenic properties of human herpesvirus 6 strains. J Inf Dis 162:852–857, 1990.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
MarÓdi, C.L., CsiszÁr, A., SIerra-Vazquez, B. et al. Studies on the antibodies to human herpesvirus type 6 among Hungarian patients with asymptomatic HIV infection. Pathol. Oncol. Res. 4, 56–61 (1998). https://doi.org/10.1007/BF02904698
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02904698